Posts filed under: News

ANMI is looking for a Logistics Manager based in Liege, Belgium. For a detailed position description, click here....
Continue Reading →
Melbourne, Australia, Feb. 28 2019 – Telix Pharmaceuticals Limited is pleased to provide its Annual Report 2018, released today. For more information click here – Annual Report 2018...
Continue Reading →
MELBOURNE Australia, 09 January 2019 – Telix Pharmaceuticals Limited is pleased to provide an update on its programs. For full details click here....
Continue Reading →
Melbourne (Australia) – 8th January 2019. Telix Pharmaceuticals Limited today announced a strategy update for the TLX591 (prostate therapy) program. The full media release can be accessed here....
Continue Reading →
Melbourne (Australia) – 3rd December 2018. Telix Pharmaceuticals Limited is pleased to provide investors an audio link to the Investor Conference Call hosted by the Company and led by Managing...
Continue Reading →
Melbourne (Australia), Brussels and Liège (Belgium) – 26th November 2018. Telix Pharmaceuticals Limited today announced that it has acquired Belgium-based Advanced Nuclear Medicine Ingredients (ANMI) SA. To facilitate shareholder queries,...
Continue Reading →
Melbourne (Australia), Brussels and Liège (Belgium) – 26th November 2018. Telix Pharmaceuticals Limited today announced that it has acquired Belgium-based Advanced Nuclear Medicine Ingredients (ANMI) SA. The full media release...
Continue Reading →
Melbourne (Australia), Brussels and Liège (Belgium) – 26th November 2018. Telix Pharmaceuticals Limited today announced that it has acquired Belgium-based Advanced Nuclear Medicine Ingredients (ANMI) SA. To facilitate shareholder queries,...
Continue Reading →
Melbourne (Australia), Brussels and Liège (Belgium) – 26th November 2018. Telix Pharmaceuticals Limited today announced that it has acquired Belgium-based Advanced Nuclear Medicine Ingredients (ANMI) SA. For market briefing click...
Continue Reading →
Melbourne (Australia), Brussels (Belgium) – 18th of October 2018. Telix Pharmaceuticals Limited has today announced that the Company has received its first European Competent Authority (CA) approval to commence a...
Continue Reading →